|
Market Closed -
Nasdaq Stockholm
19:00:00 23/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.928 SEK | -2.72% |
|
-4.55% | -2.13% |
| 10-20 | Irlab research behind linepemat published in journal | FW |
| 10-20 | IRLAB Therapeutics AB Announces Publication Of Preclinical Research Underpinning Linepemat In Peer-Reviewed Journal | CI |
Stock exchange
Nasdaq Stockholm
IRLAB A 1.928 kr
-2.72%
1.2M
kr
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| IRLAB A | 1.928SEK | -2.72% | 1.2M kr | ||
Deutsche Boerse AG
| 6IRA | 0.1738EUR | -4.51% | 0 € | |
|
OTC Markets
| IRLAF | -USD | -.--% | 0 $ |
Quotes 5-day view: IRLAB Therapeutics AB
Delayed Quote Nasdaq Stockholm
| 19/10/2026 | 20/10/2026 | 21/10/2026 | 22/10/2026 | 23/10/2026 | |
|---|---|---|---|---|---|
| Last | SEK 1.982 | SEK 2.065 | SEK 2.075 | SEK 1.982 | SEK 1.928 |
| Volume | 935,209 | 404,197 | 421,941 | 638,431 | 621,231 |
| Change | -1.88% | +4.19% | +0.48% | -4.48% | -2.72% |
| Opening | SEK 1.978 | SEK 1.960 | SEK 2.050 | SEK 2.055 | SEK 1.982 |
| High | SEK 2.060 | SEK 2.085 | SEK 2.090 | SEK 2.070 | SEK 1.982 |
| Low | SEK 1.930 | SEK 1.940 | SEK 1.996 | SEK 1.858 | SEK 1.862 |
Performance
| 1 day | -2.72% | ||
| 1 week | -4.55% | ||
| Current month | +5.59% | ||
| 1 month | +5.47% | ||
| 3 months | +51.81% | ||
| 6 months | +33.15% | ||
| Current year | -2.13% | ||
| 1 year | -21.78% | ||
| 3 years | -71.98% | ||
| 5 years | -95.58% |
Volumes
marketsDaily volume
621,231
Estimated daily volume
621,231
Avg. Volume 20 sessions
730,091
Daily volume ratio
0.85
Avg. Volume 20 sessions SEK
1,407,615.45
Avg. Volume 20 sessions USD
141,849.63
Record volume 1
4,292,354
Record volume 2
4,261,996
Record volume 3
3,636,833
Capital turnover ratio
0
Float rotation
0.01
Basic data
Market Cap (SEK)
286,601,431
Market Cap (USD)
28,881,686
Net sales (SEK)
57,462,000
Net sales (USD)
5,790,618
Number of employees
31
Sales / Employee (SEK)
1,853,613
Sales / Employee (USD)
186,794
Free-Float
83.4%
Free-Float capitalization (SEK)
136,524,015
Free-Float capitalization (USD)
13,757,935
Average Daily Capital Traded
0.49%
Indicators
Moving average 5 days
2.006
Moving average 20 days
1.888
Moving average 50 days
1.812
Moving average 100 days
1.569
Price spread / (MMA5)
+4.07%
Price spread / (MMA20)
-2.10%
Price spread / (MMA50)
-6.03%
Price spread / (MMA100)
-18.64%
RSI 9 days
57.64
RSI 14 days
58.69
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.72% | -4.55% | -21.78% | -71.98% | 28.88M | |
| -2.54% | +1.31% | +54.27% | +114.96% | 1,135B | |
| -1.42% | +3.23% | +38.56% | +74.44% | 636B | |
| +0.16% | +0.08% | +25.29% | +95.23% | 505B | |
| -0.31% | +3.09% | +44.14% | +64.80% | 378B | |
| -1.34% | -0.47% | +66.04% | +41.00% | 358B | |
| -0.68% | +2.65% | +22.98% | +50.39% | 295B | |
| -1.20% | +3.04% | +2.33% | +22.86% | 266B | |
| -1.79% | +1.57% | +50.56% | +59.08% | 237B | |
| -0.73% | -0.10% | +29.02% | +99.67% | 193B | |
| Average | -1.26% | +1.50% | +31.14% | +55.04% | 400.44B | |
| Weighted average by Cap. | -1.35% | +2.66% | +41.02% | +79.75% |
Historical Quotes: IRLAB Therapeutics AB
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
7dd27fd361006d06cd7a03b686e4ea8.niYzsE-WLUcy2yabAwMyh_wXBDMvNTksbxkBqTtppeE.wWMHyTigXgxb9n_QU2t_8r9GSGoZXnBEIUF54nIOlZPfT1ToLPd0Ike1SQ
| Date | Price | Volume | Total |
|---|---|---|---|
| 18:29:46 | 1.928 | 1,000 | 621,161 |
| 18:29:46 | 1.928 | 1,250 | 620,161 |
| 18:29:46 | 1.928 | 1,432 | 618,911 |
| 18:29:46 | 1.928 | 3,439 | 617,479 |
| 18:29:46 | 1.928 | 25 | 614,040 |
| 18:29:46 | 1.928 | 100 | 614,015 |
| 18:29:46 | 1.928 | 4 | 613,915 |
| 18:24:45 | 1.892 | 4,077 | 613,911 |
Price Extremes
| 1 week | 1.86 |  | 2.09 |
| 1 month | 1.7 | | 2.09 |
| Current year | 1.17 | | 2.14 |
| 1 year | 1.17 | | 2.78 |
| 3 years | 1.17 | | 20.2 |
| 5 years | 1.17 | | 51.5 |
| 10 years | 1.17 | | 110 |
Monthly variations
Annual variations
| 2026 | -2.13% | ||
| 2025 | -81.67% | ||
| 2024 | +43.33% | ||
| 2023 | -80.42% | ||
| 2022 | -12.95% | ||
| 2021 | +4.76% | ||
| 2020 | +14.75% | ||
| 2019 | -41.90% | ||
| 2018 | +120.28% | ||
| 2017 | +142.37% |
- Stock Market
- Stocks
- IRLAB A Stock
- Quotes IRLAB Therapeutics AB
Select your edition
All financial news and data tailored to specific country editions
